Cagle P - Search Results

1

A novel copper(II) complex identified as a potent drug against colorectal and breast cancer cells and as a poison inhibitor for human topoisomerase IIα.

Sandhaus S, Taylor R, Edwards T, Huddleston A, Wooten Y, Venkatraman R, Weber RT, González-Sarrías A, Martin PM, Cagle P, Tse-Dinh YC, Beebe SJ, Seeram N, Holder AA. Sandhaus S, et al. Among authors: cagle p. Inorg Chem Commun. 2016 Feb;64:45-49. doi: 10.1016/j.inoche.2015.12.013. Inorg Chem Commun. 2016. PMID: 26752972 Free PMC article.

2

Caspase-dependent signaling underlies glioblastoma cell death in response to the fungal metabolite, fusarochromanone.

Mahdavian E, Marshall M, Martin PM, Cagle P, Salvatore BA, Quick QA. Mahdavian E, et al. Among authors: cagle p. Int J Mol Med. 2014 Sep;34(3):880-5. doi: 10.3892/ijmm.2014.1842. Epub 2014 Jul 9. Int J Mol Med. 2014. PMID: 25016928 Free PMC article.

3

Leptin modulated microRNA-628-5p targets Jagged-1 and inhibits prostate cancer hallmarks.

Rios-Colon L, Chijioke J, Niture S, Afzal Z, Qi Q, Srivastava A, Ramalinga M, Kedir H, Cagle P, Arthur E, Sharma M, Moore J, Deep G, Suy S, Collins SP, Kumar D. Rios-Colon L, et al. Among authors: cagle p. Sci Rep. 2022 Jun 16;12(1):10073. doi: 10.1038/s41598-022-13279-x. Sci Rep. 2022. PMID: 35710817 Free PMC article.

4

MicroRNA-205-5p inhibits skin cancer cell proliferation and increase drug sensitivity by targeting TNFAIP8.

Ge X, Niture S, Lin M, Cagle P, Li PA, Kumar D. Ge X, et al. Among authors: cagle p. Sci Rep. 2021 Mar 11;11(1):5660. doi: 10.1038/s41598-021-85097-6. Sci Rep. 2021. PMID: 33707587 Free PMC article. Retracted.

5

MicroRNA-214 targets PTK6 to inhibit tumorigenic potential and increase drug sensitivity of prostate cancer cells.

Cagle P, Niture S, Srivastava A, Ramalinga M, Aqeel R, Rios-Colon L, Chimeh U, Suy S, Collins SP, Dahiya R, Kumar D. Cagle P, et al. Sci Rep. 2019 Jul 5;9(1):9776. doi: 10.1038/s41598-019-46170-3. Sci Rep. 2019. PMID: 31278310 Free PMC article.

6

Retraction Note: MicroRNA-205-5p inhibits skin cancer cell proliferation and increase drug sensitivity by targeting TNFAIP8.

Ge X, Niture S, Lin M, Cagle P, Li PA, Kumar D. Ge X, et al. Among authors: cagle p. Sci Rep. 2022 Sep 27;12(1):16103. doi: 10.1038/s41598-022-21189-1. Sci Rep. 2022. PMID: 36167756 Free PMC article. No abstract available.

7

KCNQ1OT1: An Oncogenic Long Noncoding RNA.

Cagle P, Qi Q, Niture S, Kumar D. Cagle P, et al. Biomolecules. 2021 Oct 29;11(11):1602. doi: 10.3390/biom11111602. Biomolecules. 2021. PMID: 34827600 Free PMC article. Review.

8

Knockdown of microRNA-214-3p Promotes Tumor Growth and Epithelial-Mesenchymal Transition in Prostate Cancer.

Cagle P, Smith N, Adekoya TO, Li Y, Kim S, Rios-Colon L, Deep G, Niture S, Albanese C, Suy S, Collins SP, Kumar D. Cagle P, et al. Cancers (Basel). 2021 Nov 23;13(23):5875. doi: 10.3390/cancers13235875. Cancers (Basel). 2021. PMID: 34884984 Free PMC article.

9

Glenosphere Size Does Not Matter in Reverse Total Shoulder Arthroplasty.

Patel AV, White CA, Li T, Parsons BO, Flatow EL, Cagle PJ. Patel AV, et al. Among authors: cagle pj. Rev Bras Ortop (Sao Paulo). 2024 Apr 10;59(2):e254-e259. doi: 10.1055/s-0043-1770976. eCollection 2024 Apr. Rev Bras Ortop (Sao Paulo). 2024. PMID: 38606143 Free PMC article.

10

Multimodal pain management and postoperative outcomes in inpatient and outpatient shoulder arthroplasties: a population-based study.

Liu H, Zhong H, Zubizarreta N, Cagle P, Liu J, Poeran J, Memtsoudis SG. Liu H, et al. Among authors: cagle p. Reg Anesth Pain Med. 2024 Mar 18:rapm-2023-104984. doi: 10.1136/rapm-2023-104984. Online ahead of print. Reg Anesth Pain Med. 2024. PMID: 38499359

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

323 results

Search Page